Incidence, Patient Characteristics and Outcome of Myocarditis After COVID-19 mRNA Vaccine
NCT05438472
·
clinicaltrials.gov ↗
COMPLETED
Status
835
Enrollment
OTHER
Sponsor class
Conditions
Myocarditis
Interventions
OTHER:
data collection in healthcare professionals with COVID-19 mRNA vaccine booster
Sponsor
University Hospital, Basel, Switzerland